L-dopa hypotension in dogs: evidence for mediation through 5-HT release.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001794:Blood Pressure / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002230:Carbidopa / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003864:Depression, Chemical; D004285:Dogs; D004347:Drug Interactions; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis / Q000378:metabolism*; D013997:Time Factors; D015016:Yohimbine / Q000494:pharmacology
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D008996:Monoamine Oxidase Inhibitors; D015016:Yohimbine; D012701:Serotonin; D007980:Levodopa; D012110:Reserpine; D006916:5-Hydroxytryptophan; D006220:Haloperidol; D002230:Carbidopa; D001058:Apomorphine; D010134:Fenclonine; D002746:Chlorpromazine; D009638:Norepinephrine; D008784:Methysergide